$EVEX
Eve Holding, Inc. Stock $evex

$evex Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000155485523000363 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.633M	$6.154M	$808.8K
YoY Change	2.43%	660.95%	114.44%
% of Gross Profit
Research & Development	$21.82M	$21.53M	$9.115M
YoY Change	121.86%	136.19%	382.26%
% of Gross Profit
Depreciation & Amortization	$81.08K	$22.05K	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$28.45M	$27.68M	$9.923M
YoY Change	74.45%	178.96%	2531.17%
Operating Profit	-$28.45M	-$27.68M	-$10.43M
YoY Change	74.05%	165.34%	2666.19%
Interest Expense	-$2.653M	$2.084M	$444.9K
YoY Change	-156.32%	368.48%	-96.33%
% of Operating Profit
Other Income/Expense, Net	$148.0K	$34.00K	-$22.22K
YoY Change	-1174.8%	-253.02%
Pretax Income	-$31.11M	-$25.60M	-$9.501M
YoY Change	166.97%	169.43%	-180.88%
Income Tax	$303.0K	$173.7K	$0.00
% Of Pretax Income
Net Earnings	-$31.41M	-$25.77M	-$9.501M
YoY Change	166.6%	171.26%	328.52%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.11	-$0.09	-$0.05
Diluted Earnings Per Share	-$0.11	-$0.09	-$39.29K
COMMON SHARES
Basic Shares Outstanding	269.1M shares	269.1M shares	220.0M shares
Diluted Shares Outstanding	275.6M shares	275.5M shares	220.0M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$184.4M	$211.0M	$24.68K
YoY Change	-44.26%	854668.4%	-98.36%
Cash & Equivalents	$33.59M	$11.84M	$12.51M
Short-Term Investments	$150.8M	$199.1M
Other Short-Term Assets	$1.462M	$740.7K	$84.90K
YoY Change	780.24%	772.44%	-70.61%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$270.8M	$295.5M	$109.6K
YoY Change	-18.24%	269599.44%	-93.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$513.8K	$594.3K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$236.9M
YoY Change			2.0%
Other Assets
YoY Change
Total Long-Term Assets	$1.064M	$801.5K	$236.9M
YoY Change		-99.66%	2.0%
TOTAL ASSETS
Total Short-Term Assets	$270.8M	$295.5M	$109.6K
Total Long-Term Assets	$1.064M	$801.5K	$236.9M
Total Assets	$271.9M	$296.3M	$237.1M
YoY Change	-17.92%	25.01%	1.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.351M	$490.1K	$5.709M
YoY Change	164.23%	-91.41%	2268.55%
Accrued Expenses	$2.304M	$5.046M	$972.6K
YoY Change		418.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$150.0K
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$38.59M	$32.86M	$5.859M
YoY Change	94.12%	460.89%	2330.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.531M	$976.3K	$24.67M
YoY Change	181.96%	-96.04%	-31.44%
Total Long-Term Liabilities	$1.531M	$976.3K	$24.67M
YoY Change	181.96%	-96.04%	-31.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.59M	$32.86M	$5.859M
Total Long-Term Liabilities	$1.531M	$976.3K	$24.67M
Total Liabilities	$40.12M	$33.84M	$30.53M
YoY Change	96.46%	10.84%	-15.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$274.2M	-$242.8M
YoY Change	2704.61%
Common Stock	$505.9M	$505.3M
YoY Change	57.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$231.7M	$262.5M	$3.645M
YoY Change
Total Liabilities & Shareholders Equity	$271.9M	$296.3M	$237.1M
YoY Change	-17.92%	25.01%	1.26%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$31.41M	-$25.77M	-$9.501M
YoY Change	166.6%	171.26%	328.52%
Depreciation, Depletion And Amortization	$81.08K	$22.05K	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$27.71M	-$19.89M	-$600.7K
YoY Change	120.24%	3211.54%	28.22%
INVESTING ACTIVITIES
Capital Expenditures	$121.7K	$43.70K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$49.50M	-$17.50M
YoY Change	-132.14%
Cash From Investing Activities	$49.38M	-$17.54M	$0.00
YoY Change	-132.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-287.2K	$0.00	150.0K
YoY Change	-100.09%	-100.0%	-94.81%
NET CHANGE
Cash From Operating Activities	-27.71M	-$19.89M	-600.7K
Cash From Investing Activities	49.38M	-$17.54M	$0.00
Cash From Financing Activities	-287.2K	$0.00	150.0K
Net Change In Cash	21.38M	-$37.31M	-450.7K
YoY Change	-86.84%	8178.72%	-3.8%
FREE CASH FLOW
Cash From Operating Activities	-$27.71M	-$19.89M	-$600.7K
Capital Expenditures	$121.7K	$43.70K	$0.00
Free Cash Flow	-$27.83M	-$19.93M	-$600.7K
YoY Change		3218.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25771982	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001823652
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.01	pure
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39704
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1400 General Aviation Drive
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32935
CY2023Q1	dei	City Area Code CityAreaCode	(321)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	751-5050
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	269094021	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11837193	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49146063	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	199119647	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	178781549	usd
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2023Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	198509	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	203712	usd
CY2023Q1	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	83640600	usd
CY2022Q4	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	82650375	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	740699	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1425507	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	295536648	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	312207206	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	594282	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451586	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	207176	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	216636	usd
CY2023Q1	us-gaap	Assets Assets	296338106	usd
CY2022Q4	us-gaap	Assets Assets	312875428	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	490148	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2097097	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	16222416	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	12625243	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5757000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3562500	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10393985	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6648171	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32863549	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24933011	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	976303	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1020074	usd
CY2023Q1	us-gaap	Liabilities Liabilities	33839852	usd
CY2022Q4	us-gaap	Liabilities Liabilities	25953085	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269094021	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269094021	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	220000000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	269094	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	269094	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	505009464	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	503661571	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-242780304	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-217008322	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	286922343	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	296338106	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	312875428	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21528338	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9114687	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6154319	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1318033	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27682657	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10432720	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-2194500	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	3254400	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	63381	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1024490	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	359331	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25598267	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10010008	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173715	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275494021	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275494021	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25771982	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25771982	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10010008	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2022Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	732776	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	746537	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	286922343	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25771982	usd
CY2023Q1	evex	Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense	867893	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	480000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	262498254	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25771982	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2023Q1	us-gaap	Depreciation Depreciation	22050	usd
CY2022Q1	us-gaap	Depreciation Depreciation	0	usd
CY2023Q1	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	9461	usd
CY2022Q1	evex	Noncash Lease Expenses Amortization And Interest NoncashLeaseExpensesAmortizationAndInterest	0	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	58553	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2023Q1	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	98321	usd
CY2022Q1	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	867893	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2674500	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3828323	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2023Q1	evex	Adjustments For Non Cash Carve Out Expenses Contributed From Parent AdjustmentsForNonCashCarveOutExpensesContributedFromParent	0	usd
CY2022Q1	evex	Adjustments For Non Cash Carve Out Expenses Contributed From Parent AdjustmentsForNonCashCarveOutExpensesContributedFromParent	732769	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1242627	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-5346	usd
CY2022Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-57321	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1708467	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-98593	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	3597173	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	8241343	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-9461	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3495301	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	450845	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19891123	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1868950	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	17500000	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43699	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17543699	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	125952	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37308870	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1868950	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49146063	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14376523	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11837193	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12507573	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	147665	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	121047	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	220000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20870920	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
CY2021Q4	us-gaap	Assets Assets	21570673	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	877641	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8642340	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10168363	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	evex	Net Parent Investment NetParentInvestment	10731615	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21570673	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p> <p style="margin: 8pt 0cm 0cm; text-indent: 22.5pt; line-height: 1.2; font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman', serif; line-height: inherit;"><span style="line-height: inherit;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. </span><span style="line-height: inherit;"><span style="line-height: inherit;">Under the legal entity approach, the significant estimates include, </span></span><span style="line-height: inherit;">but are not limited to the measurement of warrants, fair value measurement and income taxes.</span></span></p>
CY2023Q1	us-gaap	Cash Cash	4690191	usd
CY2022Q4	us-gaap	Cash Cash	14446534	usd
CY2023Q1	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	4137035	usd
CY2022Q4	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	4483260	usd
CY2023Q1	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	3009967	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11837193	usd
CY2023Q1	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P90D
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2023Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2023Q1	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	291984	usd
CY2022Q1	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	732776	usd
CY2023Q1	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	291984	usd
CY2022Q1	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	732776	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	16222416	usd
CY2023Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	15655522	usd
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	83839109	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	16222416	usd
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	83839109	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	16222416	usd
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	82854087	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	12625243	usd
CY2023Q1	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	15655506	usd
CY2022Q1	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	7464234	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	594282	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	451586	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	325764	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1292317	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	190579	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	34642	usd
CY2023Q1	evex	Advances To Employees AdvancesToEmployees	183215	usd
CY2022Q4	evex	Advances To Employees AdvancesToEmployees	74064	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	41141	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	24484	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	740699	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1425507	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5046325	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2491847	usd
CY2023Q1	evex	Provision For Short Term Incentive Plan ProvisionForShortTermIncentivePlan	3087531	usd
CY2022Q4	evex	Provision For Short Term Incentive Plan ProvisionForShortTermIncentivePlan	2508143	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1056677	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	763031	usd
CY2023Q1	evex	Advances From Customers Current AdvancesFromCustomersCurrent	800000	usd
CY2022Q4	evex	Advances From Customers Current AdvancesFromCustomersCurrent	800000	usd
CY2023Q1	evex	Social Charges Payable Current SocialChargesPayableCurrent	712547	usd
CY2022Q4	evex	Social Charges Payable Current SocialChargesPayableCurrent	626627	usd
CY2023Q1	evex	Long Term Incentive Plan LongTermIncentivePlan	269193	usd
CY2022Q4	evex	Long Term Incentive Plan LongTermIncentivePlan	177859	usd
CY2023Q1	evex	Advanced Payments Related To Service Arrangements AdvancedPaymentsRelatedToServiceArrangements	222020	usd
CY2022Q4	evex	Advanced Payments Related To Service Arrangements AdvancedPaymentsRelatedToServiceArrangements	300738	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	175995	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	11370288	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	7668245	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10393985	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6648171	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	976303	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1020074	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269094021	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269094021	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	220000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	11622536	shares
CY2022Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	3562500	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	917172	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.62
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M2D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13356	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.54
CY2023Q1	evex	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P2Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16050	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.27
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	914478	shares
CY2023Q1	evex	Share Based Compensation Arrangement By Share Based Payment Award Options Convertible In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConvertibleInPeriod	0	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	867893	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0067	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173715	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25771982	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275494021	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57837014	shares
CY2021Q3	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	2	number

Files In Submission

Name	View Source	Status
evex-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
evex-20230331_lab.xml	Edgar Link	unprocessable
evex-20230331_cal.xml	Edgar Link	unprocessable
evex-20230331_pre.xml	Edgar Link	unprocessable
0001554855-23-000363-index-headers.html	Edgar Link	pending
0001554855-23-000363-index.html	Edgar Link	pending
0001554855-23-000363.txt	Edgar Link	pending
0001554855-23-000363-xbrl.zip	Edgar Link	pending
evex-20230331.htm	Edgar Link	pending
evex-20230331.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex313_3.htm	Edgar Link	pending
ex321_4.htm	Edgar Link	pending
ex322_5.htm	Edgar Link	pending
ex323_6.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
evex-20230331_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVEX
Eve Holding, Inc. Stock $evex

2023 Q2 Form 10-Q Financial Statement

#000155485523000363 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX Eve Holding, Inc. Stock $evex

2023 Q2 Form 10-Q Financial Statement

#000155485523000363 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX
Eve Holding, Inc. Stock $evex